Printed from the IBC Life Sciences Web site on April 17, 2014 5:35 AM ET.
Page location: http://www.ibclifesciences.com/TIDES/advisors.xml
Online Registration is Open!
Register by May 8, 2014 to avoid the $100 on-site fee.
May 12-15, 2014 Rhode Island Convention CenterProvidence, RI
Alternative Language Options:
Kathryn L. Ackley, Ph.D., RAC, Senior Director Cincinnati Operations, Nitto Denko Avecia Inc.
Firoz Antia, Ph.D., CMC Team Director, Pharmaceutical Operations and Technology, Biogen Idec
Mimoun Ayoub, Ph.D., Vice President, Global Peptides and Injectables, Corden Pharma
Neil H. Baine, Ph.D., Past Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals (Retired)
Doug Brooks, Ph.D., Vice President, Manufacturing Development, Ophthotech Corporation
Bob D. Brown, Ph.D., Chief Scientific Officer and Senior Vice President, Research, Dicerna Pharmaceuticals
Alex Fässler, Ph.D., President and COO, Bachem Americas Inc.
Peter Hoffmann, Ph.D.
David Litzinger, Ph.D., President, David Litzinger and Associates, LLC
John P. Mayer, Ph.D., Senior Research Scientist, Department of Chemistry, Indiana University
Paul McCormac, Ph.D., Director, Biomanufacturing Sciences Group, Pfizer Global Manufacturing
Michael McGinley, Bioseparations Product Manager, Phenomenex
Bruce Morimoto, Ph.D., Executive Director Applied Translational Medicine, Drug Development Services, Celerion
Gary F. Musso, Ph.D., President, Musso and Associates LLC
Lubomir V. Nechev, Ph.D., Vice President, Process Chemistry, Alnylam Pharmaceuticals, Inc.
El Djouhar Rekaï, Head of Peptide Products Operation, Lonza, Belgium
Claus Rentel, Ph.D., Executive Director, Analytical Development Quality Control, Isis Pharmaceuticals
Christopher A. Rhodes, Ph.D., President, Christopher A. Rhodes & Associates LLC
Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Santaris Pharma A/S, Denmark
Trishul Shah, Key Account Manager, Business Development, North America, PolyPeptide Laboratories
G. Susan Srivatsa, Ph.D., President, ElixinPharma
James D. Thompson, Ph.D., Head, Process Sciences, Moderna Therapeutics, Inc.
David Tumelty, Ph.D., Director of Chemistry, New England Peptide
Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc.
Fran Wincott, Ph.D., President, Wincott & Associates, LLC
David Brown, Ph.D., Director of Research, Mirna Therapeutics, Inc.
Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals, Israel
Troels Koch, Ph.D., Vice President, Research and CTO, Santaris Pharma A/S, Denmark
Muthiah (Mano) Manoharan, Ph.D., Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals
Pamela Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals
Jesse Dong, Ph.D., Vice President, Compound Discovery, IPSEN
Tomi Sawyer, Ph.D., Past-Founding CSO, Aileron Therapeutics and Adjunct Professor, University of Massachusetts and Northeastern University
Peter Timmerman, Ph.D., Chief Scientific Officer, Pepscan Therapeutics, The Netherlands
Thomas Vorherr, Ph.D., Director Peptide Discovery, Novartis Pharma AG, Switzerland
Paul Watt, Ph.D., CEO, Phylogica Ltd., Australia